Febrile episodes without leukopenia are more important for survival than febrile leukopenia in lung cancer patients receiving chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 76s Year: 2005
Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patients Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008
The effectiveness of pegfilgrastim in preventing leucopenia in patients with lung cancer under chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005
Neutropenia in lung cancer cases after chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 753s Year: 2006
Chemotherapy induced neutropenia in lung cancer patients: a single centre study Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
The incidence of neutropenia in patients undergoing outpatient chemotherapy for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 755s Year: 2006
Aggressive skin cancers associated with prolonged voriconazole therapy in 4 lung transplant patients Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009
Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients Source: Eur Respir J 2001 Jan 01;19(4):743-755 Year: 2002
Role of flexible bronchoscopy in the management of patients with febrile neutropenia and lung infiltrates in a cancer setting hospital Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019
The use of piperacillin/tazobactam for treatment of pneumonia in neutropenic patients Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Second-line treatment patients at relapse of disseminated small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 395s Year: 2001
Evaluation of intrapericardial cisplatin (CIS) administration in cases with recurrent malignant pericardial effusion (MPE) in pts with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 63s Year: 2003
First ever report of histologically proven bronchiolitis obliterans organizing pneumonia after antineoplastic treatment of a malignant pleural mesothelioma with cisplatin and pemetrexed Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases Year: 2011
Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Survival and respiratory effects in NSCLC patients after treatment with inhaled carboplatin Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Carboplatin and paclitaxel chemotherapy for lung cancer patients with interstitial lung disease Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
A 12-week combination of clarithromycin and prednisone for the treatment of cryptogenic and radiation-induced organising pneumonia Source: International Congress 2015 – New insights into IIPs Year: 2015